Lifeline Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2009	FY 2004	FY 2003	FY 2002
Period Ending	Feb '26 Feb 13, 2026	Dec '09 Dec 31, 2009	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Market Capitalization	2	-	1	19	-
Market Cap Growth	33.33%	-	-97.34%	-	-
Enterprise Value	-	1	0	-	-
Last Close Price	0.00	0.00	16847.14	632400.21	695638976.02
PS Ratio	-	-	5.10	652.56	-
PB Ratio	0.28	-	-1.25	28.47	-
P/TBV Ratio	0.29	-	-	31.53	-
EV/Sales Ratio	-	-	3.20	-	-
Debt / Equity Ratio	0.08	0.08	-2.33	0.29	-
Net Debt / Equity Ratio	-0.02	-0.02	-1.87	-0.08	-
Net Debt / EBITDA Ratio	-	-	-0.62	0.06	-
Net Debt / FCF Ratio	-	-	-0.45	0.35	-
Asset Turnover	-	-	0.11	-	-
Quick Ratio	8.42	8.42	1.18	4.38	-
Current Ratio	8.42	8.42	2.60	4.69	-
Return on Equity (ROE)	-	-	-1210.37%	-	-
Return on Assets (ROA)	-	-	-92.94%	-	-
Return on Capital Employed (ROCE)	-8.50%	-8.50%	-241.20%	-113.80%	-
Earnings Yield	-33.01%	-	-344.50%	-4.51%	-
FCF Yield	-	-	-331.08%	-0.76%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.